thioflavin t has been researched along with Lymphoma, Non-Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, QC; Guo, Y; Huang, HQ; Lin, XB; Pan, ZH; Shi, YX; Wei, J | 1 |
| Gawrecka, G; Górski, J; Kicińska, M | 1 |
1 trial(s) available for thioflavin t and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[Clinical trial of immunoregulation using the TFX Polfa preparation in non-Hodgkin's lymphoma].
Topics: Aged; Clinical Trials as Topic; Female; Humans; Immune Tolerance; Immunologic Deficiency Syndromes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Thymus Extracts | 1988 |
1 other study(ies) available for thioflavin t and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Topics: Adolescent; Adult; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Cytokine-Induced Killer Cells; Cytokines; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Interferon-alpha; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Th1 Cells; Th2 Cells; Thymus Extracts; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2006 |